Get Professional Valuation and Credit Risk Reports of Any Company in the World

New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →

Familien Andresens selskab til fremme af medicinsk forskning A/S — Credit Rating and Financial Key Figures

CVR number: 39694395
Holmevej 180, 8270 Højbjerg
jj@galba.dk
tel: 61205609
Free credit report Annual report

Company information

Official name
Familien Andresens selskab til fremme af medicinsk forskning A/S
Established
2018
Company form
Limited company
Industry

About Familien Andresens selskab til fremme af medicinsk forskning A/S

Familien Andresens selskab til fremme af medicinsk forskning A/S (CVR number: 39694395) is a company from AARHUS. The company recorded a gross profit of -25521.2 kDKK in 2025. The operating profit was -25.5 mDKK, while net earnings were -19.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was -139.6 %, which can be considered poor and Return on Equity (ROE) was -198.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 0.5 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Familien Andresens selskab til fremme af medicinsk forskning A/S's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit-7 515.00-7 512.00-7 512.00-9 519.00-25 521.25
EBIT-7 515.00-7 512.00-7 512.00-9 519.00-25 521.25
Net earnings-4 637.10-4 781.00-4 931.00-6 685.00-19 380.90
Shareholders equity total35 864.9331 084.0026 152.0019 467.0086.30
Balance sheet total (assets)35 889.9231 109.0033 677.0019 492.0016 111.30
Net debt-2.81-0.04
Profitability
EBIT-%
ROA-15.6 %-18.3 %-19.5 %-32.2 %-139.6 %
ROE-12.1 %-14.3 %-17.2 %-29.3 %-198.2 %
ROI-15.6 %-18.3 %-22.1 %-37.6 %-254.1 %
Economic value added (EVA)-7 896.93-7 661.08-7 421.14-8 738.54-20 884.79
Solvency
Equity ratio99.9 %99.9 %77.7 %99.9 %0.5 %
Gearing
Relative net indebtedness %
Liquidity
Quick ratio1 435.61 244.44.5779.71.0
Current ratio1 435.61 244.44.5779.71.0
Cash and cash equivalents2.810.04
Capital use efficiency
Trade debtors turnover (days)
Net working capital %
Credit risk
Credit ratingBBBBBBBBBBBB

Variable visualization

ROA:-139.6%
Rating: 0/100
-20%
0%
4%
11%
24%
60%
Exclamation mark icon
Graph failed to load
Equity ratio:0.54%
Rating: 1/100
-1%
21%
50%
81%
99%
100%
Exclamation mark icon
Graph failed to load

Roles

Chairman of the board
Board member
Board member

Companies in the same industry

CreditReports API
  • Company information
  • Financial data
  • Credit risk data
  • All 400,000+ Danish companies

Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.